☆ 4.0 Article

I Know That I Was a Part of Making a Difference: Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption

AIDS RESEARCH AND HUMAN RETROVIRUSES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach

Michael J. Peluso et al.

Summary: Efforts to safely resume HIV cure clinical trials in the context of the ongoing SARS-CoV-2 pandemic require careful consideration of risk reduction for participants, study design, informed consent, participant education, and study implementation. Sharing our approach and key considerations may inform other groups seeking to resume HIV cure research in similar settings.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study

Karen L. Diepstra et al.

Summary: The study explored participant perceptions and understanding of the A5345 study, which involved an intensively monitored antiretroviral pause during chronic HIV infection. Majority of participants perceived societal and personal benefits of study participation, while also acknowledging participation risks. The findings suggest a need to periodically clarify or reiterate study-related risks and benefits throughout follow-up.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)

添加到收藏夹

Article Immunology

Motivations, barriers and experiences of participants in an HIV reservoir trial

Marie-Angelique De Scheerder et al.

Summary: The motives for participating in the ATI study were primarily linked to improving personal health and contributing to finding an HIV cure. Meanwhile, practical barriers such as difficulty in planning study visits were the main obstacles for participation. Most participants reported high satisfaction with the study and were willing to participate in future ATIs, with clear communication and guidance being key factors contributing to their positive experiences.

JOURNAL OF VIRUS ERADICATION (2021)

添加到收藏夹

Article Infectious Diseases

Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations

Lu Zheng et al.

Summary: Analytical treatment interruption (ATI) remains an essential component in clinical studies aiming to induce HIV treatment-free remission or long-term viral control. Recent ATI trial designs have evolved towards shorter interruption phases and more frequent viral load monitoring to reduce viremia risks. Common outcome measures in modern ATI trials include time to viral rebound, viral control, and viral set point, with the design driven by scientific questions and intervention mechanisms.

CURRENT HIV/AIDS REPORTS (2021)

添加到收藏夹

Article Infectious Diseases

Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research

Karine Dube et al.

Summary: The study highlights the importance of ethical considerations and risk mitigation strategies to reduce unintended HIV transmission events during Analytical Treatment Interruptions (ATIs) in HIV cure-related research. Despite uncertainties in managing sexually transmitted infections and protecting multiple or anonymous partners of ATI trial participants, providing adequate support, counseling, and referral to pre-exposure prophylaxis are crucial in protecting the welfare of individuals involved in such trials. Ethical permissibility of ATI trials relies on due diligence and informed consent to mitigate risks to participants and their sexual partners.

HIV RESEARCH & CLINICAL PRACTICE (2021)

添加到收藏夹

Letter Immunology

Unintended HIV-1 Infection During Analytical Therapy Interruption

Ainoa Ugarte et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The significance and expectations of HIV cure research among people living with HIV in Australia

Jennifer Power et al.

PLOS ONE (2020)

添加到收藏夹

Review Immunology

Altruism: Scoping review of the literature and future directions for HIV cure-related research

Karine Dube et al.

JOURNAL OF VIRUS ERADICATION (2020)

添加到收藏夹

Article Immunology

A landscape analysis of HIV cure-related clinical research in 2019

Liz Barr et al.

JOURNAL OF VIRUS ERADICATION (2020)

添加到收藏夹

Article Immunology

Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate

Jean-Daniel Lelievre et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

添加到收藏夹

Review Immunology

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting

Boris Julg et al.

LANCET HIV (2019)

添加到收藏夹

Article Ethics

Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment

Gail E. Henderson et al.

JOURNAL OF MEDICAL ETHICS (2018)

添加到收藏夹

Article Health Policy & Services

Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC)

Marie Preau et al.

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2018)

添加到收藏夹

Article Ethics

An activist's argument that participant values should guide risk-benefit ratio calculations in HIV cure research

David Evans

JOURNAL OF MEDICAL ETHICS (2017)

添加到收藏夹

Article Immunology

A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies

Mirjam J. Curno et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.